What Is a Neuropeptide Receptor? Definition and What Research Reports

Definition

A neuropeptide receptor is a protein, almost always embedded in the cell membrane, that recognises and binds a neuropeptide — a short chain of amino acids released by neurons, neurosecretory cells or certain immune and endocrine cells — and translates that binding event into a change inside the cell. The large majority of characterised neuropeptide receptors belong to the G protein-coupled receptor (GPCR) superfamily, meaning the receptor spans the membrane seven times and, once occupied by its peptide ligand, activates intracellular G proteins and downstream second messengers. Some receptors additionally require accessory proteins to reach the surface or to determine which peptide they prefer; the receptor activity-modifying protein RAMP1 is one such subunit, described in the literature as a neuropeptide receptor subunit (PMID 31109903). In short: the neuropeptide is the message, and the neuropeptide receptor is the lock that the message fits.

What Class of Molecule It Is and Where It Comes From

Neuropeptide receptors are genomically encoded proteins, not synthesised compounds. Each is the product of a gene, and in most animals studied those genes form recognisable families that can be traced across evolution. They are expressed on the surface of neurons, glia, immune cells, gut epithelium, retina and many other tissues, which is why the same receptor family can appear in a neuroscience paper and an immunology paper in the same year.

Because the receptors are gene products, a substantial part of the published literature on the term is genomic and comparative rather than pharmacological. Investigators have identified neuropeptide and neuropeptide receptor gene sets in insects — for example in Phauda flammans (PMID 35701459), in the walnut fruit moth Atrijuglans hetaohei (PMID 32199950), and in the ectoparasitoid wasp Habrobracon hebetor (PMID 33178044) — and have built curated resources such as DINeR, a database assembled for insect neuropeptide research (PMID 28502574). A 2024 analysis examined conservation of neuropeptide receptors across the phylum Nematoda (PMID 39379997), and another 2024 paper reported alterations of pleiotropic neuropeptide–receptor gene couples in Cetacea (PMID 39218857).

How the Term Is Used in Peptide Research

In practice the phrase turns up in several distinct contexts, and the meaning shifts slightly with each.

1. As a molecular target

When a paper says a peptide "acts at its neuropeptide receptor," it means the peptide binds a specific receptor protein and initiates signalling. This is the pharmacological sense of the term.

2. As a gene family in comparative genomics

Papers that "identify neuropeptide receptor genes" are typically annotating a transcriptome or genome and assigning sequences to known receptor families by homology, as was done in the insect studies noted above (PMID 35701459, PMID 33178044).

3. As an anatomical marker

Immunohistochemistry and in situ work asks where a receptor sits. A 2022 study reported the localisation of the neuropeptide receptor NPY4R in rat retina (PMID 35453028).

4. As a biomarker

Receptor genes can be assessed for epigenetic modification rather than for signalling. One analysis reported that genes encoding neuropeptide receptors functioned as epigenetic markers in patients with head and neck cancer, examined on a site-specific basis (PMID 29100314).

What the Published Literature Reports

Several strands of work illustrate what researchers have measured at neuropeptide receptors.

Kinetics. A 2016 review in Trends in Neurosciences examined the kinetic profile of neuropeptide–receptor interactions, framing how the timing of association and dissociation shapes peptide signalling rather than treating binding as a simple on/off event (PMID 27793433).

Immune signalling. A 2017 Nature study reported that the neuropeptide NMU amplified group 2 innate lymphoid cell (ILC2)-driven allergic lung inflammation, a finding that placed a neuropeptide–receptor axis inside an immune circuit rather than a purely neural one (PMID 28902842). Separately, researchers reported that the neuropeptide receptor subunit RAMP1 constrained the innate immune response during acute pancreatitis in mice (PMID 31109903).

Circuit-level signalling. A 2025 preprint described a neuropeptide-specific signalling pathway involved in state-dependent regulation of the mesolimbic dopamine system (PMID 40777293). As a preprint, that report had not completed peer review at the time of posting, which is a relevant caveat when weighing it against journal-published work.

Across these papers the recurring theme is that a neuropeptide receptor is not only a switch but a context-dependent one: the same receptor family can appear in retina, pancreas, lung and midbrain, and what the receptor does depends heavily on which cells express it.

Related Terms Often Confused With It

Limitations of the Current Literature

• A large share of the neuropeptide receptor literature is invertebrate genomics, where receptors are annotated by sequence similarity rather than confirmed by binding experiments (PMID 32199950).
• Localisation studies establish where a receptor is present, not what it does there; the rat retina NPY4R work was descriptive in scope (PMID 35453028).
• Rodent immune findings, such as the RAMP1 pancreatitis work, were conducted in mice and do not automatically transfer to humans (PMID 31109903).
• Preprints in this area, including the 2025 mesolimbic dopamine report, await peer review (PMID 40777293).

Educational Note

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question or before making any decision involving a medicine, supplement or investigational compound. Nothing here describes a protocol, and no dosing information is provided, because the cited literature summarised on this page is definitional, genomic and mechanistic rather than clinical. Many neuropeptide receptor ligands discussed in research settings are research-use-only materials that have not been approved by regulators for human use.

References

• The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation (Nature, 2017)
• A neuropeptide-specific signaling pathway for state-dependent regulation of the mesolimbic dopamine system (bioRxiv, 2025)
• Localization of neuropeptide receptor NPY4R in rat retina (Neuropeptides, 2022)
• Identification of neuropeptides and neuropeptide receptor genes in Phauda flammans (Walker) (Scientific Reports, 2022)
• Alterations of pleiotropic neuropeptide-receptor gene couples in Cetacea (BMC Biology, 2024)
• The neuropeptide receptor subunit RAMP1 constrains the innate immune response during acute pancreatitis in mice (Pancreatology, 2019)
• DINeR: Database for Insect Neuropeptide Research (Insect Biochemistry and Molecular Biology, 2017)
• Identification and expression profiling of neuropeptides and neuropeptide receptor genes in Atrijuglans hetaohei (Gene, 2020)
• Global analysis of neuropeptide receptor conservation across phylum Nematoda (BMC Biology, 2024)
• Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis (Oncotarget, 2017)
• Identification of Neuropeptides and Their Receptors in the Ectoparasitoid, Habrobracon hebetor (Frontiers in Physiology, 2020)
• Kinetic Profile of Neuropeptide-Receptor Interactions (Trends in Neurosciences, 2016)